{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:54:39Z","timestamp":1785772479534,"version":"3.56.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00105-026-05733-y","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:50:01Z","timestamp":1784040601000},"page":"508-515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrierte Versorgung der Hidradenitis suppurativa am Beispiel des EsmAiL-Projekts","Integrated care of hidradenitis suppurativa using the example of the EsmAiL project"],"prefix":"10.1007","volume":"77","author":[{"given":"Michael","family":"Schultheis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"issue":"1","key":"5733_CR1","doi-asserted-by":"publisher","first-page":"2284105","DOI":"10.1080\/09546634.2023.2284105","volume":"34","author":"M Heise","year":"2023","unstructured":"Heise\u00a0M et\u00a0al (2023) A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effectiveness. J\u00a0Dermatolog Treat 34(1):2284105","journal-title":"J Dermatolog Treat"},{"key":"5733_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jdin.2022.10.010","volume":"10","author":"XT Ooi","year":"2023","unstructured":"Ooi\u00a0XT et\u00a0al (2023) The psychosocial burden of hidradenitis suppurativa in Singapore. JAAD Int 10:89\u201394","journal-title":"JAAD Int"},{"issue":"2","key":"5733_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000431175","volume":"231","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis\u00a0CC et\u00a0al (2015) Hidradenitis Suppurativa\/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation. Dermatology 231(2):184\u2013190","journal-title":"Dermatology"},{"issue":"6","key":"5733_CR4","first-page":"868","volume":"22","author":"CC Zouboulis","year":"2024","unstructured":"Zouboulis\u00a0CC et\u00a0al (2024) S2k-Leitlinie zur Therapie der Hidradenitis suppurativa\/Acne inversa \u2013 Kurzfassung. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 22(6):868\u2013892","journal-title":"JDDG: Journal der Deutschen Dermatologischen Gesellschaft"},{"issue":"2","key":"5733_CR5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","volume":"82","author":"A Garg","year":"2020","unstructured":"Garg\u00a0A et\u00a0al (2020) Evaluating patients\u2019 unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project. J\u00a0Am Acad Dermatol 82(2):366\u2013376","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"5733_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1159\/000508787","volume":"236","author":"G Kokolakis","year":"2020","unstructured":"Kokolakis\u00a0G et\u00a0al (2020) Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System. Dermatology 236(5):421\u2013430","journal-title":"Dermatology"},{"issue":"2","key":"5733_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00403-020-02065-2","volume":"313","author":"N Kirsten","year":"2021","unstructured":"Kirsten\u00a0N, Zander\u00a0N, Augustin\u00a0M (2021) Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population. Arch Dermatol Res 313(2):95\u201399","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"5733_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/jdv.15940","volume":"34","author":"N Kirsten","year":"2020","unstructured":"Kirsten\u00a0N et\u00a0al (2020) Epidemiology of hidradenitis suppurativa in Germany - an observational cohort study based on a multisource approach. J\u00a0Eur Acad Dermatol Venereol 34(1):174\u2013179","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"5733_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/JW9.0000000000000064","volume":"8","author":"R Masson","year":"2022","unstructured":"Masson\u00a0R et\u00a0al (2022) Perspectives of obstetricians\/gynecologists on hidradenitis suppurativa care: a\u00a0survey study. Int J Womens Dermatol 8(4):e064","journal-title":"Int J Womens Dermatol"},{"key":"5733_CR10","doi-asserted-by":"crossref","unstructured":"Schultheis, M., et\u00a0al., A\u00a0centre-based, ambulatory care concept for Hidradenitis suppurativa improves disease activity, burden, and patient satisfaction: results from the randomised controlled trial EsmAiL. British Journal of Dermatology, 2023.","DOI":"10.1093\/bjd\/ljad135"},{"issue":"19","key":"5733_CR11","first-page":"345","volume":"120","author":"M Schultheis","year":"2023","unstructured":"Schultheis\u00a0M et\u00a0al (2023) Klinische Merkmale von Betroffenen mit Akne inversa. Dtsch Arztebl International 120(19):345\u2013346","journal-title":"Dtsch Arztebl International"},{"issue":"1","key":"5733_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2245082","volume":"34","author":"C Mann","year":"2023","unstructured":"Mann\u00a0C et\u00a0al (2023) Self-management-competency as a\u00a0new target in Hidradenitis suppurativa care. Journal of Dermatological Treatment 34(1):2245082","journal-title":"Journal of Dermatological Treatment"},{"key":"5733_CR13","doi-asserted-by":"crossref","unstructured":"Gulliver, W., et\u00a0al., Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa. Reviews in Endocrine and Metabolic Disorders, 2016. 17.","DOI":"10.1007\/s11154-016-9328-5"},{"issue":"5","key":"5733_CR14","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/bjd.15748","volume":"177","author":"CC Zouboulis","year":"2017","unstructured":"Zouboulis\u00a0CC et\u00a0al (2017) Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol 177(5):1401\u20131409","journal-title":"Br J Dermatol"},{"issue":"1","key":"5733_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000365390","volume":"230","author":"MK Basra","year":"2015","unstructured":"Basra\u00a0MK et\u00a0al (2015) Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data. Dermatology 230(1):27\u201333","journal-title":"Dermatology"},{"key":"5733_CR16","unstructured":"Schultheis, M., K.\u00a0Hennig, and M.\u00a0Heise, Evaluation eines strukturierten und leitlinienbasierten multimodalen Versorgungskonzepts f\u00fcr Menschen mit Akne inversa, G.\u00a0Bundesausschuss, Editor. 2024: Ergebnisbericht. p.\u00a0139."}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-026-05733-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-026-05733-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-026-05733-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:06:45Z","timestamp":1785769605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-026-05733-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5733"],"URL":"https:\/\/doi.org\/10.1007\/s00105-026-05733-y","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.\u00a0Schultheis weist auf folgende Beziehungen hin: Zusch\u00fcsse oder Vertr\u00e4ge von einer Einrichtung: LENICURA GmbH - Auditorent\u00e4tigkeit bei der Durchf\u00fchrung des Vertrages AOK-Priomed Akne inversa | Zahlungen oder Honorare f\u00fcr Vortr\u00e4ge, Pr\u00e4sentationen, Rednerb\u00fcros, Manuskriptschreiben oder Bildungsveranstaltungen: AbbVie \u2013 Honorare f\u00fcr Vortr\u00e4ge | Unterst\u00fctzung f\u00fcr die Teilnahme an Tagungen und\/oder Reisen: AbbVie, Pfizer, Novartis, UCB - Finanzierung von Reise-, Kongress- und Hotelkosten.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}